MedPath

The efficacy and safety of intraductal radiofrequency ablation in the treatment of benign bile duct tumor

Not Applicable
Conditions
Neoplasms
Registration Number
KCT0006630
Lead Sponsor
Pusan National University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

1) 20 years of age or older
2) Patients with benign bile duct tumor confirmed by biopsy
3) Patients with benign bile duct tumors who cannot or refuse surgical resection due to poor general condition
4) A person who has signed the written consent of the subject to participate in this study

Exclusion Criteria

1) Patients with recurrent bile duct tumor after radical surgery
2) Patients with malignant bile duct tumor
3) If you have other active or uncontrolled diseases
4) In case of liver dysfunction due to diseases other than benign biliary tumor
5) Patients whose general condition is so poor that treatment cannot be performed or cannot cooperate
6) Patients who refuse to participate in this study

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The clinical success rate of endoscopic intraductal radiofrequency ablation
Secondary Outcome Measures
NameTimeMethod
Early complication of endoscopic intraductal radiofrequency ablation
© Copyright 2025. All Rights Reserved by MedPath